e-learning
resources
London 2016
Tuesday, 06.09.2016
Airway response to infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Colony stimulating factors cannot correct defective phagocytosis in COPD lung tissue macrophages
Jessica Tilman (London, United Kingdom), Jessica Tilman, Peter Barnes, Louise Donnelly
Source:
International Congress 2016 – Airway response to infection
Session:
Airway response to infection
Session type:
Thematic Poster
Number:
3974
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jessica Tilman (London, United Kingdom), Jessica Tilman, Peter Barnes, Louise Donnelly. Colony stimulating factors cannot correct defective phagocytosis in COPD lung tissue macrophages. Eur Respir J 2016; 48: Suppl. 60, 3974
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Characterisation of defective phagocytosis by chronic obstructive pulmonary disease alveolar macrophages
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
The effect of
in vitro
culture methods on corticosteroid sensitivity in COPD alveolar macrophages
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
TNFalpha release by monocyte-derived macrophages at stable and exacerbation states in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Increased circulating alveolar epithelial microparticles in COPD patients
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Increased uptake of haemophilus influenzae by primary airway epithelial cells from COPD patients
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Neutrophil extracellular traps (NETs) in COPD: A potential novel mechanism for host damage in acute exacerbations
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
M2 macrophage marker CD163, CD204 and CD206 expression on alveolar macrophages in the lung of patients with chronic obstructive pulmonary
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Reduced phagocytosis of bacterial pathogens by macrophages from COPD patients
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Monocyte-derived macrophages from non-smoker COPD subjects exhibit defective bacterial phagocytosis
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Quantitative analysis of potentially pathogenic microbes (PPMs) in the induced sputum of non-smoker COPD (NS-COPD) subjects
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016
The relationship between blood eosinophils and bacterial load in COPD patients
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Altered inflammasome activity in bacterial acute exacerbations of COPD (AECOPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Neutrophil numbers are decreased in bronchial biopsies from patients with COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Macrolide effects on the prevention of COPD exacerbations
Source: Eur Respir J 2012; 40: 485-494
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept